Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Showing 1 to 3 of 3 results for febuxostat

  1. Gout: diagnosis and management (NG219)

    This guideline covers the diagnosis and management of gout. It includes recommendations on diagnosing gout, managing flares, long-term management of gout and referral to specialist services.

    NICE guideline
    Published
    9 June 2022
    View recommendations

    Sections for NG219

  2. Past appeals and decisions

    Past technology appraisal appeals and decisions

  3. Febuxostat for the management of hyperuricaemia in people with gout (TA164)

    This guidance has been updated and replaced by NICE guideline NG219.

    Technology appraisal guidance
    Published
    17 December 2008